Patients
58 % of married women 15–49
Contraception use, Philippines, 2022 (World Bank).
Compare every country on the Public Health Dashboard
Updated
Reviewed by Chandani Patel
Philippines Family Planning Products Market Industry Trends and Forecast to 2034: Segmented by (Product, Channel, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$27.2 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $38.0 Mn | — | — |
| 2025 (base) | $40.3 Mn | +$2.2 Mn | — |
| 2026 (forecast) | $42.6 Mn | +$2.4 Mn | +5.9% |
| 2027 (forecast) | $45.2 Mn | +$2.5 Mn | +12.1% |
| 2028 (forecast) | $47.8 Mn | +$2.7 Mn | +18.8% |
| 2029 (forecast) | $50.6 Mn | +$2.8 Mn | +25.8% |
| 2030 (forecast) | $53.6 Mn | +$3.0 Mn | +33.2% |
| 2031 (forecast) | $56.8 Mn | +$3.2 Mn | +41.1% |
| 2032 (forecast) | $60.1 Mn | +$3.4 Mn | +49.4% |
| 2033 (forecast) | $63.7 Mn | +$3.5 Mn | +58.2% |
| 2034 (forecast) | $67.4 Mn | +$3.8 Mn | +67.5% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $40.3 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $67.4 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 5.9% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Product and channel (see all) |
| Key players | Bayer AG, Organon, Pfizer Inc., Mylan N.V., DKT International (see all) |
| Regulator in the Philippines | FDA PhilippinesSource: Food and Drug Administration Philippines. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Family planning products help people choose if and when to have children, including pills, implants, injectables and IUDs.
Key segments of the family Planning Products market include product (Implants, Injectables and Oral Pills) and channel (Public Sector, Private Sector and NGOs).
Global health goals, donor and government funding, better mobile technology and focus on preventing disease are driving the family Planning Products market.
Digital tools for community health, local manufacturing and public-private partnerships give the family Planning Products market room to grow.
Limited budgets, weak health systems in some regions, workforce shortages and supply chain gaps hold back the family Planning Products market.
The family Planning Products market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Drug products need registration with the Food and Drug Administration of the Philippines (FDA).[1] PhilHealth is the national health insurer, and the Universal Health Care Act of 2019 makes every Filipino a member.[2] Contraception use: 58% of married women 15–49 in 2022, the latest World Bank figure for the Philippines.[3]
[1] Food and Drug Administration Philippines. Checked 14 Nov 2026.
[2] PhilHealth. Checked 14 Nov 2026.
[3] World Bank Open Data, Contraception use (% of married women 15–49). Retrieved 19 Nov 2026.
Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for family Planning Products. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in Philippines.
What doctors and scientists are doing in Family Planning Products right now, from free public sources.
58 % of married women 15–49
Contraception use, Philippines, 2022 (World Bank).
Compare every country on the Public Health DashboardSources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 19 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Contraception use (% of married women 15–49). Retrieved 19 Nov 2026.
[2] World Bank Open Data, Health spending per person (US$ per person). Retrieved 18 Nov 2026.
[3] World Bank Open Data, Doctors (per 1,000 people). Retrieved 19 Nov 2026.
From our blog
Philippines · 1 shared keyword
Philippines · 1 shared keyword
Philippines · 1 shared keyword
Philippines · 1 shared keyword
Philippines
Philippines
Healthcare Services · Philippines
Medical Devices · Philippines
Healthcare Services · Philippines
Digital Health · Philippines
Healthcare Services · Philippines
Healthcare Services · Philippines